Nanotheranostics for Diagnosis and Therapy

This book provides an updated account of recent advancements in the field of nanotechnology-based theranostics with special emphasis on their application in the diagnosis and treatment of various types of cancer and neurological diseases. The book is divided into two sections; the first section provides an introduction to the nanoscale theranostics & radiopharmaceuticals. The second section highlights the importance of nanoscale theranostics in disease diagnosis & treatment. It presents the potential of nanotechnology for developing nanomedicine and nanotheranostics for the diagnosis and treatment of a variety of illnesses. Further, the book discusses the usefulness of theranostic nanoparticles in the diagnosis of disease, identification of location, and stage, and in providing information about the therapy response. In addition, the book focuses on the clinical applications of nanomaterial radiolabeling in nuclear imaging of cancer and other illness. Towards the end, the bookexamines the toxicity, regulatory protocols, and future aspects of clinical applications of theranostics. This book is an invaluable source for academicians and industrial scientists working in multiple healthcare fields like pharmaceutical and biological sciences, life sciences, biotechnology, biomedical engineering, and nanobiotechnology.

Md. Abul Barkat, PhD, is currently serving as an Assistant Professor at the Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Kingdom of Saudi Arabia. He holds a Master's degree in Pharmaceutical Sciences from Jamia Hamdard University, New Delhi, India, and a PhD in Pharmaceutical Sciences (Pharmaceutics) from the Integral University Lucknow, India. With more than 12 years of teaching and research experience in the field of Pharmaceutical Science, his research interests include the development and optimization of herbal/synthetic based nanostructured delivery systems, controlled release drug delivery systems, bio-enhanced drug delivery systems, nanomaterials and nanocomposites for a variety of conditions like burns, cancer etc. To date he has authored more than 75 research and review publications in various peer-reviewed journals, 15 book chapters and 9 books.

Farhan Jalees Ahmad, PhD, currently Dean & Professor at School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi, India is an internationally known researcher in the area of Pharmaceutical Sciences. Having obtained his degree in M.Pharm and Ph.D (Pharmaceutics) from Jamia Hamdard, he continues to teach and leads a very productive research group which has been funded extensively by National and international funding agencies. The focus of his group has been in the area of Nanomedicine and many of his nano products have been approved by the DCGI (Drugs Controller General of India) and successfully transferred to the Defense Services for use in the armed forces. Nano DPI with a lung deposition of >60% was clinically proved in patients of COPD. He has published more than 480 publications, 12 Book chapters, 11 books and has a US patent, three PCTs and 24 Indian patents. With a total citation of 17014 and H Index of 62, Professor Ahmad's work has been clearly well received by the scientific community.

Mohammad Akhlaquer Rahman, PhD, is working as an Assistant Professor at the Department of Pharmaceutics, College of Pharmacy, Taif University, Kingdom of Saudi Arabia. He has 8 years of extensive experiences in teaching and research, published more than 40 research and review articles in referred and impact journals. He also contributed 5 book chapters with well reputed international publishers. He attended international conference (Colloids and Nanomedicine2012) in Amsterdam, Netherlands with the financial support of Government of India. He received Best Research Award-2020 by VD GoodTM Professional Association, India.

Dr. Mohammad Azam Ansari, PhD, is currently working as Associate Professor in Epidemic Diseases Research Department at the Institute for Research & Medical Consultation, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia. He has earlier served as Assistant Professor in the Department of Applied Medical Sciences, Buraidah Private Colleges, Saudi Arabia (2014-2017). Dr. Ansari earned his Ph.D. in Microbiology (Medicine) from Aligarh Muslim University, Aligarh, India in 2013. He has more than 8 years of research and teaching experience and his research work mainly focused on nanoformulation and green synthesis of nanomaterials for biomedical applications such as antimicrobial, antibiofilm, anti-quorum sensing, anticancer and nano drug delivery. He has published over 120 peer-reviewed articles in journals of international repute, 2 US patents and received numerous grants and awards. He is also member of the editorial board and reviewer for a number of international and national journals.